Morphea (Localized Scleroderma) in a COVID-19 patient: A Case Report

Journal Title: Journal of Clinical Immunology & Microbiology - Year 2021, Vol 2, Issue 1

Abstract

Since the COVID-19 pandemic raised all over the world a year ago, many dermatological manifestations have been reported in COVID-19 patients including alopecia areata, erythematous rash, widespread urticaria and chickenpox-like vesicles and Chilblain-Like Acral Skin Lesions. This is the first case reported of morphea in a 62 years old Caucasian woman diagnosed during recovery from Sars-Cov-2 pneumonia in January 2021. She presented to our clinic in Saint’ Andrea hospital in Rome with multiple white sclerotic skin lesions with erythematous halo (lilac ring) all over the trunk. After blood tests, HRCT, serological tests and skin biopsy the only clinical reference was COVID-19 infection. Therefore, knowing that COVID-19 is related to immunological mechanisms we assume that both conditions are related. The pathways of connection between morphea and COVID-19 are still unknown that’s why further studies are needed.

Authors and Affiliations

Capalbo Alessandro, Gagliostro Nazareno, Balampanos Charalampos Georgios, Bushati Vilma, Persechino Flavia, Giordano Domenico, Persechino Severino*

Keywords

Related Articles

Respiratory Syncytial Virus Infection among Children in Lagos, Nigeria

Background Information: Acute Lower Respiratory Tract Infections (ALRTIs) are among the major cause of mortality and morbidity worldwide. Respiratory Syncytial Virus (RSV) is recognized as the most important viral caus...

Another Wake-up Call for Innovative Research with Vision

An article titled “Why Tuberculosis Has Not Been Eradicated? Need for Vision and bold Innovative Research” published in 2017 was a wake-up call to Health Research Workers (HRWs) to carryout innovative research with vis...

How Fungus Can Debilitate Your Immune System?

Little is known about the precise mechanism involved in immunity to fungal infections. Researchers discovered that fungal prostaglandins, deactivate immune cells, preventing them from destroying the infection. Fungi ar...

COVID-19 Vaccination in Patients with Pre-Solid-Organ Transplantation

Vaccine such as influenza vaccine, is administered in stable transplant recipients, although live attenuated virus vaccines are contraindicated, generally due to risk of disseminated infection [1,2]. Neither efficacy,...

The Spheroid Smarting- Glomus Tumour

Glomus tumour is benign, perivascular hamartoma arising from glomus apparatus or a mesenchymal neoplasm essentially comprised of modified smooth muscle cells, also termed as glomangioma, glomangiomyoma or glomangiomato...

Download PDF file
  • EP ID EP699092
  • DOI http://dx.doi.org/10.46889/JCIM.2021.2106
  • Views 109
  • Downloads 0

How To Cite

Capalbo Alessandro, Gagliostro Nazareno, Balampanos Charalampos Georgios, Bushati Vilma, Persechino Flavia, Giordano Domenico, Persechino Severino* (2021). Morphea (Localized Scleroderma) in a COVID-19 patient: A Case Report. Journal of Clinical Immunology & Microbiology, 2(1), -. https://europub.co.uk/articles/-A-699092